Back to Agenda
PANEL DISCUSSION: LOOKING BACK AT THE 10 YEARS OF THE PAEDIATRIC LEGISLATION - THE WAYS FORWARD
Session Chair(s)
Emilie Desfontaine
Operational Investor, Jeito Capital, France
Andrea Ecker
Scientific Officer, Paediatric Medicines Office, European Medicines Agency, Netherlands
Early Paediatric Interaction and Looking back at the 10 Years of the Paediatric Legislation - the Ways Forward
Speaker(s)
Early Paediatric Interaction and Looking back at the 10 Years of the Paediatric Legislation - the Ways Forward
Florian Schmidt, JD, LLM
Deputy Head of Unit B5 – Medicines: Policy, Authorisation and Monitoring, DG SANTE, European Commission, Belgium
Early Paediatric Interaction and Looking back at the 10 Years of the Paediatric Legislation - the Ways Forward
Dirk Mentzer, DrMed, MD
PDCO Chair 2013-2019; Head of Pharmacovigilance Unit, Paul-Ehrlich-Institut, Germany
Early Paediatric Interaction and Looking back at the 10 Years of the Paediatric Legislation - the Ways Forward
Paolo Tomasi, MD, PhD
Head of Paediatric Medicines, European Medicines Agency, Netherlands
Early Paediatric Interaction and Looking back at the 10 Years of the Paediatric Legislation - the Ways Forward
Martine Dehlinger-Kremer, PhD
Sn Drug Development Strategy Lead Pediatrics, UCB Biosciences, Germany
Early Paediatric Interaction and Looking back at the 10 Years of the Paediatric Legislation - the Ways Forward
Mark Turner, MD, PhD, MRCP, FFPM
Chief Executive Officer of the c4c- Stichting (c4c-S) & Professor of Neonatology, University of Liverpool, United Kingdom
Early Paediatric Interaction and Looking back at the 10 Years of the Paediatric Legislation - the Ways Forward
Kerry Leeson-Beevers
National Development Manager, Alström Syndrome UK, United Kingdom
Have an account?